Aethlon Medical Inc financial data

Symbol
AEMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
11555 Sorrento Valley Road, Suite 203, San Diego, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
BISHOP EQUITIES INC (to 3/13/2000)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 371 % -51.4%
Debt-to-equity 38.6 % +93.8%
Return On Equity -71.7 % -46.6%
Return On Assets -116 % -66.3%
Operating Margin -6.92K % -538%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14M shares +460%
Common Stock, Shares, Outstanding 14M shares +460%
Entity Public Float 5.5M USD -58.3%
Common Stock, Value, Issued 14K USD +460%
Weighted Average Number of Shares Outstanding, Basic 13.9M shares +461%
Weighted Average Number of Shares Outstanding, Diluted 13.9M shares +461%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 162K USD -79.5%
Revenue from Contract with Customer, Excluding Assessed Tax 574K USD +95.2%
Research and Development Expense 1.89M USD -19.3%
General and Administrative Expense 3.45M USD -14.9%
Operating Income (Loss) -11.6M USD +2.81%
Net Income (Loss) Attributable to Parent -11.3M USD +3.12%
Earnings Per Share, Basic -2.83 USD/shares +55.8%
Earnings Per Share, Diluted -2.83 USD/shares +55.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.86M USD -32.6%
Cash, Cash Equivalents, and Short-term Investments 250K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 7.14M USD -31.9%
Property, Plant and Equipment, Net 844K USD -29.7%
Operating Lease, Right-of-Use Asset 744K USD -27%
Assets 8.85M USD -31%
Accounts Payable, Current 923K USD +34.7%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.33M USD +36.3%
Operating Lease, Liability, Noncurrent 497K USD -37.8%
Liabilities 2.83M USD +12.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.97K USD +58.5%
Retained Earnings (Accumulated Deficit) -160M USD -7.58%
Stockholders' Equity Attributable to Parent 6.02M USD -41.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.77M USD -61.7%
Liabilities and Equity 8.85M USD -31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD +29.6%
Net Cash Provided by (Used in) Financing Activities 5.38M USD +399%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 14M shares +460%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.95M USD -32.3%
Deferred Tax Assets, Valuation Allowance 33.3M USD +10.8%
Deferred Tax Assets, Gross 33.3M USD +10.8%
Operating Lease, Liability 798K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1M USD -23.9%
Property, Plant and Equipment, Gross 1.11M USD +12.4%
Operating Lease, Liability, Current 302K USD +7.84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 333K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 324K USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60.3K USD -43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 343K USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 26.9M USD +11.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 343K USD
Additional Paid in Capital 166M USD +4.37%
Depreciation, Depletion and Amortization 86.1K USD -4.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD